The Association Between HSD3B1 Genotype and Steroid Metabolism in Normal and Prostate Cancer Tissue of Men With Intermediate and High-risk Prostate Cancer Undergoing Radical Prostatectomy After Treatment With ARN-509 and Leuprolide
Phase of Trial: Phase II
Latest Information Update: 25 Jan 2018
At a glance
- Drugs Apalutamide (Primary) ; Leuprorelin (Primary)
- Indications Prostate cancer
- Focus Pharmacodynamics
- 18 Jan 2018 Planned primary completion date changed from 1 Oct 2017 to 1 Dec 2018.
- 12 Dec 2016 Status changed from not yet recruiting to recruiting.
- 20 May 2016 New trial record